HPV 16 E7E6
Showing 1 - 25 of >10,000
HPV Infection, HPV-Related Cervical Carcinoma Trial (FluBHPVE6E7, Placebo)
Not yet recruiting
- HPV Infection
- HPV-Related Cervical Carcinoma
- FluBHPVE6E7
- Placebo
- (no location specified)
Apr 24, 2023
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +5 more
- Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
- Pembrolizumab
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)
Not yet recruiting
- Oropharyngeal Cancer
- +10 more
- Fludarabine
- +2 more
- (no location specified)
Dec 14, 2022
Head and Neck Squamous Cell Carcinoma, Melanoma, Cervical Cancer Trial in United States (RPTR-168)
Terminated
- Head and Neck Squamous Cell Carcinoma
- +2 more
- RPTR-168
-
Scottsdale, Arizona
- +3 more
Dec 2, 2022
Human Papillomavirus-Related Carcinoma, Human Papillomavirus Positive Oropharyngeal Carcinoma, Human Papillomavirus Positive
Active, not recruiting
- Human Papillomavirus-Related Carcinoma
- +5 more
- HPV Specific T Cells
- +3 more
-
Houston, TexasHouston Methodist Hospital
Jan 10, 2022
HPV Infection Trial in Vienna (FluBHPVE6E7)
Recruiting
- HPV Infection
- FluBHPVE6E7
-
Vienna, AustriaMedical University of Vienna
Sep 23, 2021
Human Papillomavirus Type 16, Cervical Intraepithelial Neoplasia Grade II, Cervical Intraepithelial Neoplasia, Grade III Trial
Recruiting
- Human Papillomavirus Type 16
- +2 more
-
Baltimore, MarylandJohns Hopkins University
Jul 2, 2021
Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Stage IB3 Cervical Cancer FIGO 2018, Stage II
Recruiting
- Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified
- +13 more
- Cisplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 31, 2022
Cervical Carcinoma Trial in Chongqing (TC-E202 cells, IL-2, Fludarabine)
Recruiting
- Cervical Carcinoma
- TC-E202 cells
- +3 more
-
Chongqing, Chongqing, ChinaXiaochun Cheng
Oct 20, 2022
HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T
Not yet recruiting
- HPV-Associated Cervical Carcinoma
- +16 more
- Conditioning, E7 TCR-T cells, and aldesleukin
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 17, 2023
Head and Neck Squamous Cell Carcinoma Trial in Seoul (GX-188E+GX-I7+Pembrolizumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
May 18, 2022
Head and Neck Squamous Cell Carcinoma Trial in Seoul (nivolumab-GX-188E-GX-I7)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Apr 20, 2022
Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)
Not yet recruiting
- Cervical Cancer
- +20 more
- E7 TCR-T cells
-
New Brunswick, New Jersey
- +1 more
Jan 18, 2023
HPV-associated Oropharyngeal Cancer
Recruiting
- PREDICTIVE BIOMARKERS
- +2 more
- HPV-ASSOCIATED OROPHARYNGEAL CANCER
-
Rome, Italy"Regina Elena" National Cancer Institute
Oct 19, 2023
Head Neck Cancer Trial in Little Rock (PepCan, Placebo)
Recruiting
- Head and Neck Cancer
- PepCan
- Placebo
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Oct 18, 2022
HPV-Associated Cancers Trial in Canada, United States (Ad-E6E7, MG1-E6E7, Atezolizumab)
Active, not recruiting
- HPV-Associated Cancers
- Ad-E6E7
- +2 more
-
Miami, Florida
- +7 more
Sep 30, 2021
Cancer of Head and Neck, Cancer of Cervix, Cancer of Anus Trial in Boston (DPX-E7 vaccine)
Active, not recruiting
- Cancer of Head and Neck
- +2 more
- DPX-E7 vaccine
-
Boston, MassachusettsDana-Farber Cancer Institute
Feb 18, 2022
Unresectable Head and Neck Squamous Cell Carcinoma, Metastatic Head Neck Cancer, Recurrent Head Neck Cancer Trial in Worldwide
Recruiting
- Unresectable Head and Neck Squamous Cell Carcinoma
- +2 more
- BNT113
- Pembrolizumab
-
Los Angeles, California
- +79 more
Jan 9, 2023
Oropharyngeal Cancer Trial in Canada (Radiation, Cisplatin)
Active, not recruiting
- Oropharyngeal Cancer
- Radiation
- Cisplatin
-
Prince George, British Columbia, Canada
- +13 more
Dec 12, 2022
Cervical Intraepithelial Neoplasia, Cervical Cancer, Condylomata Acuminata Trial in Nanjing, Chengdu (Nonavalent HPV vaccine,
Active, not recruiting
- Cervical Intraepithelial Neoplasia
- +2 more
- Nonavalent HPV vaccine
- Bivalent HPV vaccine
-
Nanjing, Jiangsu, China
- +1 more
Feb 10, 2022
Papillomavirus Infections, Oropharyngeal Tumors Trial run by the NCI (E7 T-Cell Receptor (TCR))
Terminated
- Papillomavirus Infections
- Oropharyngeal Neoplasms
- E7 T-Cell Receptor (TCR)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 3, 2022
Cervical Intraepithelial Neoplasia Trial in Little Rock (PepCan, Candin®)
Active, not recruiting
- Cervical Intraepithelial Neoplasia
- PepCan
- Candin®
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
May 17, 2022
Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Measles Trial in Shaoxing, Wuyi
Active, not recruiting
- Human Papilloma Virus Infection Type 16
- +4 more
- HPV+MMR(0d),HPV(6m)
- +2 more
-
Shaoxing, Zhejiang, China
- +1 more
Mar 14, 2022